105 related articles for article (PubMed ID: 34865614)
1. Association between
Gao X; Yang J; Wang D; Zeng Q; Li F; Zhou S; Zhang X; Fan C; Gao Z; Zhao Y
Nucleosides Nucleotides Nucleic Acids; 2022; 41(1):85-96. PubMed ID: 34865614
[TBL] [Abstract][Full Text] [Related]
2. [Association between HULC gene locus rs7763881 polymorphism and recurrence and metastasis after radical resection in hepatocellular carcinoma].
Qi XF; Sun DJ; Ye XZ; Xu BQ; Wei ZH; Li HT
Zhonghua Gan Zang Bing Za Zhi; 2023 Mar; 31(3):281-287. PubMed ID: 37137854
[No Abstract] [Full Text] [Related]
3. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
4. Association Between lncRNA HULC rs7763881 Polymorphism and Gastric Cancer Risk.
Hong JH; Jin EH; Chang IA; Kang H; Lee SI; Sung JK
Pharmgenomics Pers Med; 2020; 13():121-126. PubMed ID: 32308466
[TBL] [Abstract][Full Text] [Related]
5. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients.
Shaker OG; Senousy MA; Elbaz EM
Sci Rep; 2017 Nov; 7(1):16246. PubMed ID: 29176650
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk is associated with the HULC rs7763881, MTMR3 rs12537 polymorphisms, and serum levels of HULC and MTMR3 in Egyptian patients.
Elhelaly M; Shaker OG; Ayeldeen G; Elsergany AR; Mostafa N
Mol Biol Rep; 2023 Dec; 50(12):10073-10081. PubMed ID: 37910386
[TBL] [Abstract][Full Text] [Related]
7. Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer.
Xu B; Zhu Y; Tang Y; Zhang Z; Wen Q
Med Sci Monit; 2018 Oct; 24():7057-7071. PubMed ID: 30286050
[TBL] [Abstract][Full Text] [Related]
8. Significant association among the Fas -670 A/G (rs1800682) polymorphism and esophageal cancer, hepatocellular carcinoma, and prostate cancer susceptibility: a meta-analysis.
Liu T; Zuo L; Li L; Yin L; Liang K; Yu H; Ren H; Zhou W; Jing H; Liu Y; Kong C
Tumour Biol; 2014 Nov; 35(11):10911-8. PubMed ID: 25085585
[TBL] [Abstract][Full Text] [Related]
9. An updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer risk.
Li H; Diao S; Li J; Ma B; Yuan S
Oncotarget; 2017 Apr; 8(17):28888-28896. PubMed ID: 28415817
[TBL] [Abstract][Full Text] [Related]
10. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.
Wang BG; Lv Z; Ding HX; Fang XX; Wen J; Xu Q; Yuan Y
Gene; 2018 Sep; 670():148-154. PubMed ID: 29803923
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms of MIR-149 gene rs2292832 contributes to the risk of hepatocellular carcinoma, but not overall cancer: a meta-analysis.
Jia H; Yu H; Liu Q
Minerva Med; 2016 Aug; 107(4):259-69. PubMed ID: 27348444
[TBL] [Abstract][Full Text] [Related]
12. Effect of long non-coding RNA highly up-regulated in liver cancer (HULC) on the prognosis of cancer: a meta-analysis.
Li Y; Liu YH; Chen X; Zhu YJ; Zhang HB; Li Y; Bai JP; Liu LR; Qu YC; Qu X
Oncotarget; 2017 Oct; 8(47):83246-83250. PubMed ID: 29137338
[TBL] [Abstract][Full Text] [Related]
13. miR-146a rs2910164 and hepatocellular carcinoma: a meta-analysis.
Dong S; Miao AY; Lei W; Chen QW
Minerva Med; 2017 Jun; 108(3):287-292. PubMed ID: 27886162
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.
Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG
Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963
[TBL] [Abstract][Full Text] [Related]
15. Association between KIF1B rs17401966 genetic polymorphism and hepatocellular carcinoma susceptibility: an updated meta-analysis.
Luo YY; Zhang HP; Huang AL; Hu JL
BMC Med Genet; 2019 Apr; 20(1):59. PubMed ID: 30947687
[TBL] [Abstract][Full Text] [Related]
16. Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis.
Tang S; Zhang J; Mei TT; Guo HQ; Wei XH; Zhang WY; Liu YL; Liang S; Fan ZP; Ma LX; Lin W; Liu YR; Qiu LX; Yu HB
BMC Cancer; 2019 Nov; 19(1):1128. PubMed ID: 31752753
[TBL] [Abstract][Full Text] [Related]
17. Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Klec C; Gutschner T; Panzitt K; Pichler M
Expert Opin Ther Targets; 2019 Mar; 23(3):177-186. PubMed ID: 30678498
[TBL] [Abstract][Full Text] [Related]
18. The Value of lncRNA HULC as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis.
Chen X; Lun L; Hou H; Tian R; Zhang H; Zhang Y
Cell Physiol Biochem; 2017; 41(4):1424-1434. PubMed ID: 28315877
[TBL] [Abstract][Full Text] [Related]
19. [Long non-coding RNA HULC affects downstream-related targets to regulate migration and invasion of hepatoma cells].
Zhou C; Wu H; Liu Y; Yin C; Yang B
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):513-518. PubMed ID: 30317774
[No Abstract] [Full Text] [Related]
20. XPD Asp312Asn polymorphism and esophageal cancer risk: an update meta-analysis based on 3928 cases and 6012 controls.
Guo XF; Wang J; Lei XF; Zeng YP; Lv XG; Dong WG
Int J Clin Exp Med; 2014; 7(9):2443-52. PubMed ID: 25356096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
